Resource Effective Strategies to Prevent and Treat Cardiovascular Disease

J D Schwalm1, Martin McKee2, Mark D Huffman2

  • 1From Population Health Research Institute and Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (J.D.S., S.Y.); Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, United Kingdom (M.M.); and Departments of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (M.D.H.). schwalj@mcmaster.ca.

Circulation
|February 24, 2016
PubMed

Insights

Cardiovascular disease (CVD) prevention is challenging globally, especially in low-income nations. Resource-efficient strategies targeting tobacco use, hypertension, and simplified care delivery can significantly reduce CVD mortality.

Area of Science:

  • Public Health
  • Cardiology
  • Health Systems Research

Background:

  • Cardiovascular disease (CVD) is the leading cause of global mortality.
  • Prevention of CVD is suboptimal worldwide, with significant evidence-practice gaps in low- and middle-income countries.
  • Barriers exist at patient, healthcare provider, and health system levels, hindering optimal CVD prevention.

Purpose of the Study:

  • To identify barriers to CVD prevention in resource-constrained settings.
  • To inform effective strategies for reducing CVD evidence-practice gaps.
  • To highlight resource-efficient strategies for reducing premature CVD mortality.

Main Methods:

  • Review of novel, resource-efficient strategies for CVD prevention.
  • Focus on modifiable risk factors: tobacco use, hypertension, and secondary prevention.
  • Analysis of strategies including simplified screening, cost-effective treatments, and task-sharing.

Main Results:

  • Effective tobacco control measures are crucial.
  • Simplified screening and management algorithms improve CVD care.
  • Affordable, simplified treatment regimens and task-sharing enhance healthcare delivery.

Conclusions:

  • Addressing barriers in resource-constrained settings is essential for CVD mortality reduction.
  • Targeting modifiable factors like tobacco use and hypertension yields significant gains.
  • Implementing these strategies can substantially reduce CVD burden and related deaths.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
576
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
827
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K